NCT07544446Recrutement en cours
What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?
Résumé
When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and/or in cases of high stress, seek psycho-oncological support. This study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services. Participants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months. The study was developed by patients. It is being conducted simultaneously at several hospitals.
Critères d'inclusion
• Patients with an oncological disease diagnosed within the last 3 months with planned or ongoing systemic oncologic treatment (e.g. chemotherapy, immunotherapy, hormone therapy) or a planned or ongoing radiotherapy • Patient is ≥18 years of age and legally competent • Patients must have understood and signed the study information and the informed consent form • Patients are willing and able to complete scheduled follow-up evaluations / questionnaires as described in the informed consent • No previous contact with psycho-oncological services
Critères d'exclusion
• Documented severe functional impairment according to the ECOG Performance Status (ECOG 3-4) • Patients receiving or planned to receive treatments associated with a severe risk of toxicity (e.g., CAR-T cell therapy, myeloablative therapy) • Insufficient language skills in German • Inability to give informed consent • Refusal to participate in the study, unsigned informed consent
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- Sans phase (N/A)
- Type d'étude
- Interventionnelle
- Pays
- Suisse
- Promoteur
- Lindenhofgruppe AG(Industrie)
- N° de protocole
- Schobinger_24-02_PIP_PICS
- Pathologies
- Cancer, Psycho-Oncology
- Interventions
- Autre
Traitements évalués
- initial psycho-oncological contact
- Standard
Collaborateurs
Insel Gruppe AG, University Hospital Bern, St. Claraspital AG, Klinik Hirslanden, Zurich
Lieux · 1
- Bern, SuisseLindenhofgruppeRecrute dans ce centre
Au total, dans le monde, 1 des 5 centres listés au registre recrute ; les 4 autres ne recrutent pas actuellement.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 2 septembre 2026).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.